Search Results
Search for other papers by Adile Begüm Bahçecioğlu in
Google Scholar
PubMed
Search for other papers by Alptekin Gürsoy in
Google Scholar
PubMed
Search for other papers by Serpil Dizbay Sak in
Google Scholar
PubMed
Search for other papers by Seyfettin Ilgan in
Google Scholar
PubMed
Search for other papers by Banu Bilezikçi in
Google Scholar
PubMed
Search for other papers by Murat Faik Erdoğan in
Google Scholar
PubMed
Introduction Ultrasonographic (US) echogenic microfoci (EMF) are frequently seen in papillary thyroid carcinoma (PTC). European Thyroid Association, the American College of Radiology (ACR), and the Korean Society of Thyroid Radiology classify
Search for other papers by Amanda La Greca in
Google Scholar
PubMed
Search for other papers by Bin Xu in
Google Scholar
PubMed
Search for other papers by Ronald Ghossein in
Google Scholar
PubMed
Search for other papers by R. Michael Tuttle in
Google Scholar
PubMed
Search for other papers by Mona M. Sabra in
Google Scholar
PubMed
Introduction Multifocal involvement of the thyroid gland is a well-recognized feature of papillary carcinoma. The reported frequency is about 20%, with wide variations depending on the extent of the sampling and reporting by the pathologist
Search for other papers by Eun Kyung Jang in
Google Scholar
PubMed
Search for other papers by Dong Eun Song in
Google Scholar
PubMed
Search for other papers by Gyungyub Gong in
Google Scholar
PubMed
Search for other papers by Jung Hwan Baek in
Google Scholar
PubMed
Search for other papers by Yun Mi Choi in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Ji Min Han in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
-10% [ 3 , 4 , 5 ]. It is very rare to have a result of no evidence of malignancy by histological evaluation of the thyroid in patients with a preoperative cytological diagnosis of papillary thyroid carcinoma (PTC) [ 6 , 7 ]. One report noted disappearing
Search for other papers by Ian D Hay in
Google Scholar
PubMed
Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed
Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed
Introduction Adults with low-risk ( 1 ) papillary thyroid carcinoma (PTC) represent the commonest endocrine malignancy ( 2 ). In 2017, Pontius and colleagues ( 3 ) demonstrated, in a study of 244,040 PTC patients managed in USA during 2004
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Alexandra Stephenson in
Google Scholar
PubMed
Search for other papers by Shideh Mirhadi in
Google Scholar
PubMed
Search for other papers by Konrad Patyra in
Google Scholar
PubMed
Search for other papers by Michael F Moran in
Google Scholar
PubMed
Search for other papers by Moosa Khalil in
Google Scholar
PubMed
Department of Pediatrics, Turku University Hospital, Turku, Finland
Search for other papers by Jukka Kero in
Google Scholar
PubMed
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Department of Medicine, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
-dependent compensatory mechanisms ( 11 ). However, most interestingly, our data strongly suggest that a permanently active TSHR can lead to the malignant transformation of thyrocytes. After 12 months, papillary thyroid carcinoma (PTC) occurred in both heterozygous (HEZ
Search for other papers by Pedro Weslley Souza Rosario in
Google Scholar
PubMed
Search for other papers by Gabriela Franco Mourão in
Google Scholar
PubMed
Search for other papers by Pedro Henrique Lopes Oliveira in
Google Scholar
PubMed
Search for other papers by Tulio Henrique Silva in
Google Scholar
PubMed
Introduction Patients with small papillary thyroid carcinomas (PTC) can currently be maintained under active surveillance (AS) instead of being submitted to immediate surgery [ 1 - 5 ]. This management is accepted for cases in which the risk
Search for other papers by Eijun Nishihara in
Google Scholar
PubMed
Search for other papers by Yoshitaka Hobo in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Miyoko Higuchi in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Mitsuru Ito in
Google Scholar
PubMed
Search for other papers by Shuji Fukata in
Google Scholar
PubMed
Search for other papers by Mitsushige Nishikawa in
Google Scholar
PubMed
Search for other papers by Takashi Akamizu in
Google Scholar
PubMed
measurement on structural recurrence in TgAb-positive patients with papillary thyroid carcinoma (PTC), we compared the Tg values of our Tg-LC-MS/MS with a commercially available electrochemiluminescence immunoassay for Tg (Tg-ECLIA). Furthermore, we elucidated
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Marko Stojanović in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Sandra Pekić in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Mirjana Doknić in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Dragana Miljić in
Google Scholar
PubMed
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Slavica Ćirić in
Google Scholar
PubMed
Endocrine Surgery Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Aleksandar Diklić in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Svetislav Tatić in
Google Scholar
PubMed
Search for other papers by Miloje Joksimović in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Emilija Manojlović-Gačić in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Milica Skender-Gazibara in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Vera Popović in
Google Scholar
PubMed
insipidus or ophthalmoplegia indicate a metastatic nature of the lesion, particularly in the presence of primary malignancy. Papillary thyroid carcinoma (PTC) rarely metastasizes to the central nervous system. What This Case Report Adds • This case
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Takumi Kudo in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Minoru Kihara in
Google Scholar
PubMed
Search for other papers by Takuya Higashiyama in
Google Scholar
PubMed
Search for other papers by Tomonori Yabuta in
Google Scholar
PubMed
Search for other papers by Hiroo Masuoka in
Google Scholar
PubMed
Search for other papers by Hisakazu Shindo in
Google Scholar
PubMed
Search for other papers by Kaoru Kobayashi in
Google Scholar
PubMed
Search for other papers by Akihiro Miya in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common malignancy in the endocrine organs. Papillary thyroid carcinoma is the representative pathological type, constituting about 90% of thyroid cancers. Papillary carcinoma generally shows an indolent
Search for other papers by Sang-Hyeon Ju in
Google Scholar
PubMed
Search for other papers by Yong Bae Ji in
Google Scholar
PubMed
Search for other papers by Minchul Song in
Google Scholar
PubMed
Search for other papers by Joung Youl Lim in
Google Scholar
PubMed
Search for other papers by Da Beom Heo in
Google Scholar
PubMed
Search for other papers by Min-Gyu Kim in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Yea Eun Kang in
Google Scholar
PubMed
Search for other papers by Eu Jeong Ku in
Google Scholar
PubMed
Search for other papers by Mijin Kim in
Google Scholar
PubMed
Search for other papers by Eun Kyung Lee in
Google Scholar
PubMed
Search for other papers by June Young Choi in
Google Scholar
PubMed
Search for other papers by Hyeong Won Yu in
Google Scholar
PubMed
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Search for other papers by Jun-Ho Choe in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Search for other papers by the MASTER study group † in
Google Scholar
PubMed
.6–4.8% between 2003 and 2019 ( 4 ). Consequently, given the resulting prevalence of low-risk papillary thyroid carcinoma (PTC) patients and the burden posed by the potential complications, active surveillance (AS) has received increased attention ( 6 , 7